Provided by Tiger Fintech (Singapore) Pte. Ltd.

FOSUN PHARMA

23.180
+0.1000.43%
Volume:2.25M
Turnover:52.28M
Market Cap:61.64B
PE:20.41
High:23.440
Open:23.120
Low:22.740
Close:23.080
52wk High:29.000
52wk Low:12.202
Shares:2.66B
HK Float Shares:540.97M
Volume Ratio:1.69
T/O Rate:0.42%
Dividend:0.35
Dividend Rate:1.51%
EPS(LYR):1.136
ROE:6.75%
ROA:1.32%
PB:1.17
PE(LYR):20.41
PS:1.42

Loading ...

AH Stock Premium Statistics | September 19

Stock News
·
Sep 19

AH Statistics | September 17

Stock News
·
Sep 17

Market Chatter: Henlius Biotech in Talks With J&J, Roche on Cancer Drug Rights; Shares Up 3%

MT Newswires Live
·
Sep 16

Fosun Pharma Unit Gets China Nod for Two Drug Registration Applications

MT Newswires Live
·
Sep 15

Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. (600196.SH): New Indication Application for Fuweisili Citrate Capsules Approved

Stock News
·
Sep 15

AH Stock Statistics | September 15

Stock News
·
Sep 15

AH Premium Statistics for September 11

Stock News
·
Sep 11

AH Stock Statistics | September 10

Stock News
·
Sep 10

Hong Kong Stock Concept Tracker | Multiple Innovative Drug Companies Have Key Research Selected for WCLC Oral Presentations, Current Period May Still Present Optimal Timing for Innovative Drug Allocation (with Concept Stocks)

Stock News
·
Sep 10

Morgan Stanley Initiates Buy Rating on FOSUN PHARMA (02196) with A-Share Target Price of 42 RMB and H-Share Target Price of 33 HKD

Stock News
·
Sep 09

Fosun Pharmaceutical Unit Gets China Nod for Lung Cancer Drug Trial

MT Newswires Live
·
Sep 08

Fosun Pharma's (600196.SH) Subsidiary Henlius Receives US FDA Approval for HLX17 Clinical Trial

Stock News
·
Sep 08

AH Stock Statistics | September 8

Stock News
·
Sep 08

AH Statistics | September 5

Stock News
·
Sep 05

Fosun Pharmaceutical Gets US FDA's Nod for Osteoporosis Drug

MT Newswires Live
·
Sep 02

AH Stock Statistics | September 1

Stock News
·
Sep 01

Over 2.8 Billion RMB! Fosun Pharma Subsidiary Delivers Outstanding First-Half Performance

Deep News
·
Aug 29

FOSUN PHARMA (02196): Fosun Pharma Industry Signs License Agreement with Akeso

Stock News
·
Aug 29

Hong Kong Stock Alert | FOSUN PHARMA (02196) Surges Nearly 5% in Early Trading as Interim Net Profit Jumps Nearly 40% YoY, Grants Overseas Development Rights to Sitala

Stock News
·
Aug 28

FOSUN PHARMA (02196): Drug Registration Application for Vincristine Sulfate Injection Accepted by National Medical Products Administration

Stock News
·
Aug 26